Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jack Bergman, Ph.D.

Co-Author

This page shows the publications co-authored by Jack Bergman and Rajeev Desai.
Connection Strength

5.386
  1. Influence of experimental history on nicotine self-administration in squirrel monkeys. Psychopharmacology (Berl). 2016 06; 233(12):2253-63.
    View in: PubMed
    Score: 0.675
  2. Nicotinic effects of tobacco smoke constituents in nonhuman primates. Psychopharmacology (Berl). 2016 05; 233(10):1779-89.
    View in: PubMed
    Score: 0.669
  3. Nicotine-Targeting Nano-Vaccines for Smoking Cessation. Neuropsychopharmacology. 2016 Jan; 41(1):377-8.
    View in: PubMed
    Score: 0.663
  4. Effects of the Nanoparticle-Based Vaccine, SEL-068, on Nicotine Discrimination in Squirrel Monkeys. Neuropsychopharmacology. 2015 Aug; 40(9):2207-16.
    View in: PubMed
    Score: 0.626
  5. Methamphetamine-like discriminative-stimulus effects of nicotinic agonists. J Pharmacol Exp Ther. 2014 Mar; 348(3):478-88.
    View in: PubMed
    Score: 0.577
  6. Analysis of tolerance and behavioral/physical dependence during chronic CB1 agonist treatment: effects of CB1 agonists, antagonists, and noncannabinoid drugs. J Pharmacol Exp Ther. 2013 Feb; 344(2):319-28.
    View in: PubMed
    Score: 0.535
  7. Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds. J Pharmacol Exp Ther. 2010 Dec; 335(3):807-16.
    View in: PubMed
    Score: 0.459
  8. Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux. J Pharmacol Exp Ther. 2010 Jun; 333(3):834-43.
    View in: PubMed
    Score: 0.442
  9. Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys. Eur J Pharmacol. 2007 Mar 08; 558(1-3):98-106.
    View in: PubMed
    Score: 0.353
  10. Involvement of Nicotinic Receptor Subtypes in the Behavioral Effects of Nicotinic Drugs in Squirrel Monkeys. J Pharmacol Exp Ther. 2018 08; 366(2):397-409.
    View in: PubMed
    Score: 0.196
  11. Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in rats. Behav Pharmacol. 2007 Dec; 18(8):745-54.
    View in: PubMed
    Score: 0.095
  12. Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine. Psychopharmacology (Berl). 2018 05; 235(5):1371-1387.
    View in: PubMed
    Score: 0.048
  13. N-Methyl-d-aspartate receptor co-agonist availability affects behavioral and neurochemical responses to cocaine: insights into comorbid schizophrenia and substance abuse. Addict Biol. 2019 01; 24(1):40-50.
    View in: PubMed
    Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.